The different ligand-binding modes of relaxin family peptide receptors RXFP1 and RXFP2

Molecular Endocrinology

Volumn 26, Issue 11, 2012, Pages 1896-1906

  Scott, Daniel J ^a   Johan Rosengren, K ^b   Bathgate, Ross A D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT KINASE 2; MEMBRANE PROTEIN; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR 1; RELAXIN FAMILY PEPTIDE RECEPTOR 2; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CHEMICAL ENGINEERING; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

AMINO ACID SEQUENCE; AMINO ACIDS; CONSERVED SEQUENCE; CYCLIC AMP; HEK293 CELLS; HUMANS; INSULIN; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECOMBINANT PROTEINS; RELAXIN; SEQUENCE ALIGNMENT;

EID: 84868087243     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1188     Document Type: Article

References (29)

1. Bathgate RAD, Hsueh AJ, Sherwood OD 2006 Physiology and molecular biology of the relaxin peptide family. In: (Secondary Bathgate RAD, Hsueh AJ, Sherwood OD) (Neill JD, ed. Physiology of reproduction. 3rd ed. San Diego: Elsevier; 679-770
2. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ 2006 International Union of Pharmacology: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:7-31
3. Hsu SY, Liang SG, Hsueh AJ 1998 Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seventransmembrane region. Mol Endocrinol 12:1830-1845
4. Scott DJ, Layfield S, Yan Y, Sudo S, Hsueh AJ, Tregear GW, Bathgate RA 2006 Characterization of novel splice variants of LGR 7 and LGR 8 reveals that receptor signaling is mediated by their unique LDLa modules. J Biol Chem 281:34942-34954
5. Hopkins EJ, Layfield S, Ferraro T, Bathgate RA, Gooley PR 2007 The NMR solution structure of the relaxin (RXFP 1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation. J Biol Chem 282:4172-4184
6. Kern A, Agoulnik AI, Bryant-Greenwood GD 2007 The low-density lipoprotein class A module of the relaxin receptor (leucine-rich repeat containing G-protein coupled receptor 7): its role in signaling and trafficking to the cell membrane. Endocrinology 148:1181-1194
7. Scott DJ, Wilkinson TN, Zhang S, Ferraro T, Wade JD, Tregear GW, Bathgate RA 2007 Defining the LGR 8 residues involved in binding insulin-like peptide 3. Mol Endocrinol 21:1699-1712
8. Büllesbach EE, Schwabe C 2005 The trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7. J Biol Chem 280: 14051-14056
9. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295:671-674
10. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, Hsueh AJ 2003 H 3 relaxin is a specific ligand for LGR 7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278:7855-7862
11. Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, Summers RJ 2005 Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR 7 and LGR 8). J Pharmacol Exp Ther 313:677-687
12. Hartley BJ, Scott DJ, Callander GE, Wilkinson TN, Ganella DE, Kong CK, Layfield S, Ferraro T, Petrie EJ, Bathgate RAD 2009 Resolving the unconventional mechanisms underlying RXFP 1 and RXFP 2 receptor function. Ann NY Acad Sci 1160:67-73
13. Scott DJ, Tregear GW, Bathgate RAD 2009 Modelling the primary binding site of RXFP 1 and RXFP 2. Ann NY Acad Sci 1160:74-77
14. Rosengren KJ, Zhang S, Lin F, Daly NL, Scott DJ, Hughes RA, Bathgate RA, Craik DJ, Wade JD 2006 Solution structure and characterization of the receptor binding surface of insulin-like peptide 3. J Biol Chem 281:28287-28295
15. Shabanpoor F, Hughes RA, Bathgate RA, Zhang S, Scanlon DB, Lin F, Hossain MA, Separovic F, Wade JD 2008 Solid-phase synthesis of europium-labeled human INSL 3 as a novel probe for the study of ligand-receptor interactions. Bioconjug Chem 19:1456-1463
16. Zheng L, Baumann U, Reymond JL 2004 An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 32:e115
17. Hossain MA, Rosengren KJ, Zhang S, Bathgate RA, Tregear GW, van Lierop BJ, Robinson AJ, Wade JD 2009 Solid phase synthesis and structural analysis of novel A-chain dicarba analogs of human relaxin-3 (INSL 7) that exhibit full biological activity. Org Biomol Chem 7:1547-1553
18. Yan Y, Scott DJ, Wilkinson TN, Ji J, Tregear GW, Bathgate RA 2008 Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function. Biochemistry 47:6953-6968
19. Chen W, Shields TS, Stork PJ, Cone RD 1995 A colorimetric assay for measuring activation of Gs-and Gq-coupled signaling pathways. Anal Biochem 226:349-354
20. Dominguez C, Boelens R, Bonvin AM 2003 HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125:1731-1737
21. Büllesbach EE, Schwabe C 2006 The mode of interaction of the relaxin-like factor (RLF) with the leucine-rich repeat G proteinactivated receptor 8. J Biol Chem 281:26136-26143
22. He XL, Bazan JF, McDermott G, Park JB, Wang K, Tessier-Lavigne M, He Z, Garcia KC 2003 Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 38:177-185
23. Büllesbach EE, Schwabe C 2005 LGR 8 signal activation by the relaxin-like factor. J Biol Chem 280:14586-14590
24. Hossain MA, Rosengren KJ, Haugaard-Jönsson LM, Zhang S, Layfield S, Ferraro T, Daly NL, Tregear GW, Wade JD, Bathgate RA 2008 The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. J Biol Chem 283:17287-17297
25. Del Borgo MP, Hughes RA, Bathgate RA, Lin F, Kawamura K, Wade JD 2006 Analogs of insulin-like peptide 3 (INSL 3) B-chain are LGR 8 antagonists in vitro and in vivo. J Biol Chem 281:13068-13074
26. Shabanpoor F, Bathgate RA, Hossain MA, Giannakis E, Wade JD, Hughes RA 2007 Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL 3) B-chain. J Pept Sci 13:113-120
27. Shabanpoor F, Zhang S, Hughes RA, Hossain MA, Layfield S, Ferraro T, Bathgate RA, Separovic F, Wade JD 2011 Design and development of analogues of dimers of insulin-like peptide 3 Bchain as high-affinity antagonists of the RXFP 2 receptor. Biopolymers 96:81-87
28. Fan QR, Hendrickson WA 2005 Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433:269-277
29. Jiang X, Liu H, Chen X, Chen PH, Fischer D, Sriraman V, Yu HN, Arkinstall S, He X 2012 Structure of follicle-stimulating hormone in complex with the entire ectodomain of its receptor. Proc Natl Acad Sci USA 109:13491-12496